AML With Mutated NPM1
specificAn acute myeloid leukemia (AML) with mutation of the nucleophosmin gene. It is usually associated with normal karyotype. It is seen in 8% of children with AML.
32
Centers
48
Active Trials
—
Cancer Funding
Top Centers for AML With Mutated NPM1(32)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | NCI Comprehensive Active Research Program | 62.8 |
| 2 | NCI Comprehensive Active Research Program | 62.8 |
| 3 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 62.8 |
| 4 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 62.8 |
| 5 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 62.8 |
| 6 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 62.8 |
| 7 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 62.8 |
| 8 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 62.8 |
| 9 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 62.8 |
| 10 | Stephenson Cancer CenterOklahoma City, OK NCI Clinical Active Research Program | 62.8 |
| 11 | University of Illinois Cancer CenterChicago, IL Active Research Program | 62.8 |
| 12 | Boston University Cancer CenterBoston, MA Active Research Program | 62.8 |
| 13 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program | 62.8 |
| 14 | Cancer Center at IllinoisUrbana, IL Active Research Program | 62.8 |
| 15 | Stony Brook Cancer CenterStony Brook, NY Active Research Program | 62.8 |
| 16 | Georgia Cancer Center, Augusta UniversityAugusta, GA Active Research Program | 62.8 |
| 17 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 40.3 |
| 18 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 40.3 |
| 19 | Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive Active Research Program | 40.3 |
| 20 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive Active Research Program | 40.3 |
| 21 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 40.3 |
| 22 | NCI Comprehensive Active Research Program | 40.3 |
| 23 | NCI Comprehensive Active Research Program | 40.3 |
| 24 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 40.3 |
| 25 | Wilmot Cancer Institute, UR MedicineRochester, NY NCI Clinical Active Research Program | 40.3 |
| 26 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 40.3 |
| 27 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program | 40.3 |
| 28 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 40.3 |
| 29 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program | 40.3 |
| 30 | The University of Vermont Cancer CenterBurlington, VT Active Research Program | 40.3 |
| 31 | Northwell Health Cancer InstituteNew York, NY Active Research Program | 40.3 |
| 32 | Louisiana Cancer Research CenterNew Orleans, LA Active Research Program | 40.3 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →